UNSPSC 51283720: Cefotiam dihydrochloride

This classification denotes a cephalosporin antibiotic with the molecular formula C18H23N9O4S3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H7V12WDZ93, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)-amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)-thio)methyl)-8-oxo-, hydrochloride, (6r-trans)-, but more generally known as cefotiam dihydrochloride, which bears US NIH Compound Identifier 47896. Cefotiam dihydrochloride is the dihydrochloride salt of cefotiam.

UNSPSC 51283720 Cefotiam dihydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code show minimal alignment with the nominal scope. The two opportunities on record involve pharmaceutical procurement but address different drug products entirely — one covers antibiotic tablets (Doxycycline and Ciprofloxacin) through a piggyback cooperative purchasing vehicle, and the other concerns opioid-reversal agents and drug deactivation equipment (Naloxone and associated systems) for public health response. State and local governments use UNSPSC pharmaceutical codes to organize emergency medical supply, routine healthcare inventory, and public health initiative purchasing across health departments, county health systems, and community health agencies. The issuing bodies include state departments of public health and county government health divisions, which procure through piggyback cooperative agreements, competitive invitation-for-bid (IFB) processes, and direct purchase vehicles.

Geographic activity appears concentrated in the South and Midwest, with the Illinois Department of Public Health and Seminole County, Florida both active in the recent record. The Illinois procurement, posted August 28, 2026, awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium for a 12-month initial term with two one-year renewal options, closing September 11, 2026. The Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2026, sought annual supply of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, under a two-year contract with one-year renewal option. The code shows limited recent volume and appears to carry mismatched tagging — vendors evaluating activity under this specific UNSPSC number should verify alignment with actual product requirements in each solicitation rather than relying on code nomenclature.